Universal Access and Affordable Medicines

Recommendations for unleashing meaningful innovation through regulatory reform

by European Public Health Alliance | Nov 10, 2020 | Universal Access and Affordable Medicines | Latest Developments, Universal Access and Affordable Medicines | Publications

What do we know when a new medicine is approved? What are the regulatory requirements for new medicines? What happens once a new drug is on the market?Following the first of the EPHA #A2MDialogues, our panelists Andrea Cipriani, Lydie Meheus, Huseyin Naci and Beate...

Public health must be the leading priority of Europe’s pharmaceutical sector

by European Public Health Alliance | Jul 13, 2020 | Universal Access and Affordable Medicines | Latest Developments, Universal Access and Affordable Medicines | Publications

The EU must ensure access to affordable and quality medicines in Europe whilst guaranteeing everyone’s right to a healthy and sustainable environment. Human medicine is not an ordinary commodity – public interest and public health should prevail as leading...

Patients can’t wait any longer for action on medicine shortages

by European Public Health Alliance | Apr 27, 2020 | Universal Access and Affordable Medicines | Latest Developments, Universal Access and Affordable Medicines | Publications

DOWNLOAD THE PAPER DOWNLOAD THE PR The increasing levels of medicine shortages across Europe pose severe threats to patient outcomes, patient safety and the patient care continuum. The European Public Health Alliance (EPHA) calls for an urgent resolution of the...

BeNeLuxA et al.: the best is yet to come

by Yannis Natsis | Dec 28, 2019 | Universal Access and Affordable Medicines | Publications

Download the analysis The intergovernmental regional initiatives of collaboration around access to medicines policy are here to stay. Zooming in on the BeNeLuxA coalition, the most advanced of the regional European clusters (henceforth the regionals), this reflection...

EPHA Response to public consultation on EMA Regulatory Science to 2025

by European Public Health Alliance | Jul 2, 2019 | Universal Access and Affordable Medicines | Publications

Click on the button below to read EPHA’s response to the public consultation on “EMA Regulatory Science to 2025”. DOWNLOAD CONSULTATION...

Getting it right: EPHA recommendations on how to improve the European Commission proposal on Health Technology Assessment (HTA)

by European Public Health Alliance | Jul 11, 2018 | Universal Access and Affordable Medicines | Publications

EPHA welcomes the European Commission proposal for a Regulation on Health Technology Assessment (HTA), amending Directive 2011/24/EU. We believe strongly in Health Technology Assessment as a powerful ally of patients and healthcare systems. Our recommendations aim to...